![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, October 22, 2018 6:18:19 PM
If there IS a plan for Cannophen to be a SINGULAR strain or treatment for one specific ailment, the company has done NOTHING to present it as such. My gut tells me this pink sheet stock/shell company eventually will produce a hemp derived (not marijuana) CBD capsule called "Cannophen" so they can sell it online, claiming to help with everything that ails. There are HUNDREDS of such products on the market presently. Nothing special by any means.
If I have misinterpreted, blame the lack of specifics from the company. You are of course encouraged to dig through the press releases and come to your own conclusions.
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM